Arthrosamid injection: A new treatment for osteoarthritis

Arthrosamid injections represent a promising new approach for managing osteoarthritis (OA), particularly for those with knee osteoarthritis seeking non-surgical pain relief. Osteoarthritis, a degenerative joint disease, affects millions globally and can cause persistent pain, inflammation, and reduced mobility as joint cartilage gradually wears down.

Arthrosamid injections, using a gel-like formulation, are designed to reduce pain and improve function, giving patients an innovative option to manage OA symptoms effectively.

What does the Arthrosamid injection do?

Arthrosamid injections contain a patented hydrogel, a substance made from cross-linked polyacrylamide and water. Once injected into the knee joint, this gel integrates into the surrounding soft tissue, creating a cushioning layer.

This cushion helps reduce friction and shock in the joint, effectively easing pain and limiting further damage to the cartilage. The injection is minimally invasive and typically administered as an outpatient procedure, requiring no anaesthesia and minimal downtime.

What patients can expect

Patients receiving Arthrosamid often experience significant pain reduction within weeks of the injection. Unlike corticosteroid injections, which may provide short-term relief but eventually wear off, Arthrosamid offers more sustained relief.

The hydrogel’s structure remains in the joint for extended periods, delivering benefits that can last up to several years for some patients. This long-lasting effect can be especially helpful for individuals who may not be ready or eligible for knee replacement surgery but need an effective pain management solution to improve their daily mobility.

Benefits

One of the key advantages of Arthrosamid injections over other treatments is their low risk of side effects. Traditional treatments, such as corticosteroids and hyaluronic acid injections, may provide relief but can have adverse effects on the joint over time. Arthrosamid’s biocompatibility with joint tissues minimizes the likelihood of inflammation and allows for multiple treatments if necessary.

While Arthrosamid may not reverse joint degeneration, it can significantly improve comfort and quality of life for OA patients. It is a valuable option for those seeking an alternative to surgery or those for whom traditional medications and physical therapy have proven insufficient. As clinical research continues, Arthrosamid injections could become a widely accessible solution, helping millions manage osteoarthritis pain more effectively and safely.